Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nahdi Medical CoSAU:4164 -0.17%56 EV-to-EBIT is 13.82 as of Sep. 22, 2026, which is 25% below its 10-year median of 18.41. GuruFocus rates SAU:4164 with a GF Score™ of 56/100 and a GF Value™ of ﷼135.96 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 481 Healthcare Providers & Services companies, Nahdi Medical Co ranks better than 53.64% on this metric.
The historical rank and industry rank for Nahdi Medical Co's EV-to-EBIT or its related term are showing as below:
SAU:4164'
s EV-to-EBIT Range Over the Past 10 Years
Min: 13.37 Med: 18.41 Max: 26.6
Current: 14.16
During the past 9 years, the highest EV-to-EBIT of Nahdi Medical Co was 26.60. The lowest was 13.37. And the median was 18.41.
SAU:4164's EV-to-EBIT is ranked better than 53.64% of 481
companies
in the Healthcare Providers & Services industry
Industry Median: 15.08
vs SAU:4164: 14.16
Nahdi Medical Co (SAU:4164) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Nahdi Medical Co's Enterprise Value for the quarter that ended in Jun. 2026 was ﷼13,334 Mil.
Nahdi Medical Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ﷼942 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nahdi Medical Co EV-to-EBIT Related Terms
Nahdi Medical Co EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Nahdi Medical Co's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Nahdi Medical Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nahdi Medical Co EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nahdi Medical Co's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Nahdi Medical Co's EV-to-EBIT falls into.
Nahdi Medical Co's current Enterprise Value is ﷼13,017 Mil.
Nahdi Medical Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ﷼942 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nahdi Medical Co (SAU:4164) has a EV-to-EBIT of 13.82 as of Sep. 22, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Nahdi Medical Co and its competitors. This is 25% below median its historical median of 18.41. Over the past decade, Nahdi Medical Co's EV-to-EBIT has ranged from 13.37 to 26.60. According to the industry distribution chart, Nahdi Medical Co ranks #223 out of 481 companies in the Healthcare Providers & Services industry, placing it in the top 46.4%.
Is Nahdi Medical Co's EV-to-EBIT too high?
Nahdi Medical Co's current EV-to-EBIT of 13.82 is 25% below median its 10-year median of 18.41. Over the past 10 years, this metric has ranged from a low of 13.37 to a high of 26.60. The Healthcare Providers & Services industry median EV-to-EBIT is 15.08. Nahdi Medical Co's value of 13.82 is 8.4% below this industry median. Based on the distribution chart, Nahdi Medical Co ranks #223 out of 481 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Nahdi Medical Co has a GF Score™ of 56/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nahdi Medical Co's EV-to-EBIT compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Nahdi Medical Co ranks #223 out of 481 companies for EV-to-EBIT. This puts Nahdi Medical Co in the upper half of its industry. The industry median EV-to-EBIT is 15.08. Nahdi Medical Co's value of 13.82 is 8.4% below this benchmark. Historically, Nahdi Medical Co's own EV-to-EBIT has ranged from 13.37 to 26.60 over the past decade. While the company's 10-year median is 18.41 vs. the industry median of 15.08, Nahdi Medical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.08, based on 481 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nahdi Medical Co's current EV-to-EBIT of 13.82 is 8.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Nahdi Medical Co and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nahdi Medical Co's current EV-to-EBIT is 13.82, which is 25% below median its own 10-year median of 18.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nahdi Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Nahdi Medical Co (SAU:4164) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼135.96, compared to a current price of ﷼91.15 — trading 33% below its estimated fair value. The current EV-to-EBIT is 13.82, which is 25% below median its 10-year median of 18.41 and 8.4% below the Healthcare Providers & Services industry median of 15.08. Nahdi Medical Co's overall GF Score™ is 56/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Nahdi Medical Co (SAU:4164), the current EV-to-EBIT is 13.82 as of Sep. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nahdi Medical Co (SAU:4164) Overvalued in 2026?
Based on GuruFocus' analysis, Nahdi Medical Co stock appears to be undervalued.
The current stock price of ﷼91.15 is trading 33% below its estimated GF Value™ of ﷼135.96.
GuruFocus considers Nahdi Medical Co to be Significantly Undervalued.
Key valuation signals for SAU:4164:
EV-to-EBIT: 13.82 (25% below median its 10-year median of 18.41)
GF Value™: ﷼135.96 vs. price of ﷼91.15 (33% below fair value)
Industry Position: 8.4% below the Healthcare Providers & Services median (#223 of 481)
No single metric tells the full story. See the SAU:4164 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nahdi Medical Co is engaged in the wholesale and retail trading of cosmetics, pharmaceutical products, special and healthy foods, and medical equipment. It has two operating segments: Front Shop and Pharma.
56GF Score
Get the complete analysis for SAU:4164
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4164 has been successfully added to your 
